Pioglitazone as adjuvant therapy in chronic hepatitis C: sequential rather than concomitant administration with pegylated interferon and ribavirin?

J Hepatol. 2009 Jun;50(6):1269-71. doi: 10.1016/j.jhep.2009.02.014. Epub 2009 Mar 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Chemotherapy, Adjuvant
  • Drug Administration Schedule
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / metabolism
  • Hepatitis C, Chronic / virology
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Insulin Resistance
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Male
  • Pioglitazone
  • Polyethylene Glycols / administration & dosage
  • RNA, Viral / blood
  • Recombinant Proteins
  • Ribavirin / administration & dosage
  • Thiazolidinediones / administration & dosage*

Substances

  • Antiviral Agents
  • Hypoglycemic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Thiazolidinediones
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a
  • Pioglitazone